Canada -
English -
Health Canada
anzemet tablet
sanofi-aventis canada inc - dolasetron mesylate - tablet - 50mg - dolasetron mesylate 50mg - 5-ht3 receptor antagonists
Canada -
English -
Health Canada
anzemet tablet
sanofi-aventis canada inc - dolasetron mesylate - tablet - 100mg - dolasetron mesylate 100mg - 5-ht3 receptor antagonists
Canada -
English -
Health Canada
anzemet injection 20 mg/ml solution
sanofi-aventis canada inc - dolasetron mesylate - solution - 20mg - dolasetron mesylate 20mg - 5-ht3 receptor antagonists
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
anzemet 50mg tablets
amdipharm plc - dolasetron mesilate - oral tablet - 50mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
anzemet 200mg tablets
amdipharm plc - dolasetron mesilate - oral tablet - 200mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
anzemet iv 100mg/5ml solution for injection ampoules
amdipharm plc - dolasetron mesilate - solution for injection - 20mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
anzemet iv 12.5mg/0.625ml solution for injection ampoules
amdipharm plc - dolasetron mesilate - solution for injection - 20mg/1ml